Michael Major

26PUBLICATIONS
216CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Mar 20, 2026
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.

Tito A Sandoval, Yize Li, Naoshad Muhammad

|Dec 19, 2025
A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer Growth.

Nilotpal Roy, Tine Wyseure, I-Chung Lo

|Oct 11, 2025
Activating NRF2<sup>E79Q</sup> mutation alters the differentiation of human non-small cell lung cancer.

Samera H Hamad, Hansa Joshi, T Hess

|Sep 15, 2025
Mapping of the hSOX10 protein interactome in human melanoma.

Catherine M Newsom-Stewart, Dhaval P Bhatt, Michael B Major

|Sep 13, 2025
NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting.

Harit Panda, Natalie G Rowland, Caroline M Krall

Pageof 5